Pages
- About GIST
- Carney Triad
- Diagnosis & Pathology Results
- Familial GIST
- For New GIST Patients
- Extra Pathology Samples
- FAQs
- Finding Good Care
- GIST Clinics and Doctors
- GIST Tissue Banks
- Grieving the Loss of Normal
- Monitoring Tests
- Mutation Testing
- Newbie Orientation
- Reaching Out to Your Nurse
- The pathology of SDH-deficient cancer mutation testing
- Understanding Your Pathology Report
- What to Ask Your Doctor
- Further Reading and References
- GIST with a BRAF Mutation
- GIST with a NF1 mutation
- Mutation Analysis: Kit and PDGFRA
- Pediatric GIST
- Prognosis
- SDH-deficient GIST
- What is GIST?
- Wildtype GIST
- About GSI
- Ask the Professional
- Adjuvant Imatinib Opinions
- Avapritinib Could Deliver Precision Medicine to Patients with GIST, Says Heinrich
- Cancer Prevention Diet
- Case History of A Family with GIST
- Discovery of the Carney Triad
- Effects of Imatinib (Gleevec) on GIST Cells
- Esophageal GIST
- Genetic Factors In GIST
- Genetics of Carney-Stratakis Syndrome and Carney Triad
- GIST and the LIVER
- GIST Nomogram to Predict Recurrence-Free Survival
- GIST Pathology and Prognosis
- GIST with PDGFR Alpha Mutations
- HSP90 Inhibitors and GIST
- Human Side of Cancer
- Imaging GIST Response to Treatment
- Kidney Function and GIST Drugs
- Nutrition and GI Issues After GIST Surgery
- Nutritional Needs After Gastrointestinal Surgery
- PET Imaging for GIST
- Question: Can a needle biopsy be harmful?
- Radiation Exposure from CT Scans
- Radiation Treatment for GIST
- Resistance Mutations in GIST
- Skin-Related Side Effects of Imatinib & Sunitinib
- Social Security Disability
- Sunitinib (Sutent) Experience in Use
- Sunitinib and Hypertension
- Surgical Considerations
- Switch Pocket Kinase Inhibitors
- The Cell Cycle as a Drug Target
- Thyroid Damage from Tyrosine Kinase Inhibitors
- Z9001 Adjuvant Gleevec Trial
- Blog
- Disclaimer
- GSI Community
- GIST Summits
- Join our GIST Community
- Voices of GIST
- Essays
- 8 Years and Counting!
- A GIST Chronicle
- A Miracle in Disguise
- An Angel Called Ann Charlott
- Bicycle Duty
- Brenda's War on GIST
- Carolina's Essay: Life is Great!
- Conversations with the Moon by Wendy Reed
- Dancing with Ned
- Dean, Remembrance by Mel Heller, MD
- Faith and GIST
- Faith, Ourselves, and Attitudes Toward Treatment Options by Mel Heller, MD
- Friends
- Girl In A Closet
- Gleevec Side Effects and Tips
- Grape Soda By Marina Symcox
- Happy Birthday to our Anna
- Here's to a giant group hug! By Janice Gabriel
- I was navigating a room full of strange faces by Marina Symcox
- It's OK When You Don't Feel Up
- Last Marathon By Marina Symcox
- Live Life Like You're Dying
- Lois' Christmas Tree
- Louise's 4th of July Celebration
- Maura's Essay by Maura Cesarini
- Medicine and the Web Bev's Tips by Beverly Shirts
- Reacting to a Cancer Diagnosis
- Reflections Series
- Shining Lights
- Some Words of Encouragement
- Something Important and Wonderful
- The Very Best Doctors by Bev Shirts
- Tips on things to do before going into the Hospital by Louise Ladd
- To Those Feeling Despair or Hopelessness
- Today marks the first anniversary of my GIST diagnosis by Darlene Rigg
- Waiting, The Cancer Patient
- What I Can Do with GIST
- When the traveling gets hard by Mel Heller, MD
- Stories of Strength
- Video Galleries
- Wildtype GIST Webcasts
- Essays
- Home
- Hope Connections
- News and Events
- "Mutation Matters" - Blueprint medicines educational resource
- Blueprint announces Phase 3 trial of Avapritinib
- FDA Grants Priority Review to Genentech’s Peraonalized Medicine Entrectinib
- Generous Donation from Deciphera
- GIST tumors linked to NF1 mutations, genetic testing needed
- New gene fusions identified
- NEW GIST SURVEY OPPORTUNITY
- New trials for patients with secondary mutations in the activation loop
- News from the 2018 American Society for Clinical Oncology (ASCO) Annual Meeting
- Phase 2 MEK kinase inhibitor trial at the NIH for NF-1 linked GIST
- Phase 3 Invictus (DCC-2618) trial open
- Phase I/II trial for GIST patients with a NTRK gene fusion
- Recent Advances in managing GIST
- SPAEN Annual conference February 2019
- Removed Hidden Pages
- Resources & Educational Materials
- Abdominal Anatomy
- Archived GIST Publications
- Best Links
- Books about GIST
- CancerCare Booklet on GIST
- Cells, Cancer, and More
- Computers and Internet Surfing
- Folleto de GIST en espanol
- GIST brochure
- GIST Publications
- Glossary of Terms
- Links
- Nutrition for Cancer Survivors
- Posters
- Summaries from Medical Meetings
- Understanding Your GIST Pathology Report
- Site Map
- Template Pages
- Blog Masonry
- Blog Masonry with Sidebar
- Checkout
- Contact
- Donate Now
- Events
- Events Calendar Full Width
- Events Grid
- Events Grid with Sidebar
- Events list Future/Past
- Gallery 2 Columns with pagination
- Gallery 3 Columns with pagination
- Gallery 4 Columns
- Gallery 4 Columns with pagination
- Join Us For
- My Account
- Projects Grid
- Projects Grid with Sidebar
- Projects Listing
- Shop
- Shortcodes
- Typography
- Thank You
- Treatments
- AMG 386
- Amuvatinib (MP470)
- Angiogenesis Inhibitors
- AUY922
- Clinical Trials
- Clinical Trials for GIST Cancer
- Dovitinib (TKI258)
- GIST Patients' Right to Treatment
- GIST Treatment Guidelines
- Gleevec
- Hepatic Artery Embolization
- Masitinib (AB1010)
- Off-Label Use of FDA-Approved Drugs
- Ponatinib (Iclusig)
- Radiofrequency Ablation (RFA)
- Stivarga (regorafenib)
- Surgery for GIST
- Sutent
- Tyrosine Kinase Inhibitors
- Vatalanib (PTK787)
- Work In Progress
- GIST Tumors Linked to NF1 Mutations, Genetic Testing Needed
- KIT receptor and brain injury
- Marina comments on Phase I trials and DCC 2618
- most cancers have a greater dependency on changes in genes' expression (80%) rather than on mutations (16%)
- New Mechanisms of mTOR Pathway Activation in KIT-mutant Malignant GISTs
- Recurrence-Free Survival in GIST at 90% with Long-Term Imatinib
- Reducing the Cost of Cancer Care: When Less is More
- Succinate dehydrogenase deficiency in a PDGFRA mutated GIST
- Trial Home Page
- 2017 Agenda